Therefore, in vitro test on breast cancer cells harboring the active FFL (PDGF/FLT1/SHC1) using small molecule inhibitor drugs such as sunitinib, which also targets the PDGF receptors, could be an interesting validation experiment in the future. The gene discussed is FLT1; the disease is breast carcinoma.